Legislators have made the business almost impossible. The regulatory barriers to creating a new drug are immense and the IP laws give very little protection. F

Legislators have made the business almost impossible. The regulatory barriers to creating a new drug are immense and the IP laws give very little protection. Further, many countries will simply ignore IP laws if a drug is successful. We need to figure this out so that investment will be made.